Globus Medical Inc
Change company Symbol lookup
Select an option...
GMED Globus Medical Inc
ACC American Campus Communities Inc
BAC Bank of America Corp
ANDOF Alumindo Light Metal Industry Tbk PT
PCAR Paccar Inc
VMI Valmont Industries Inc
JPM JPMorgan Chase & Co
KCLI Kansas City Life Insurance Co
PRU Prudential Financial Inc
RLI Rli Corp
Go

Health Care : Health Care Equipment & Supplies | Small Cap Growth
Company profile

Globus Medical, Inc. is a medical device company. The Company is focused on developing products for patients with musculoskeletal disorders. It is focused on products to treat patients with spine disorders. The Company's products fall under categories, which include Innovative Fusion and Disruptive Technologies. The Innovative Fusion category products include fusion products to treat spinal disorders for the entire spine, and they can be used in various surgical approaches. The Disruptive Technologies category represents a shift in the treatment of spinal disorders by allowing for surgical procedures and the treatment of spinal disorders. QUARTEX is its Occipito-Cervico-Thoracic (OCT) stabilization system. QUARTEX features a threading locking cap to enable low-torque. The Company's portfolio of approved and pipeline Disruptive Technology products includes products that allow for minimally invasive surgical (MIS) techniques.

Postmarket

Last Trade
Delayed
$0.00
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$59.62
Day's Change
-0.46 (-0.77%)
Bid
--
Ask
--
B/A Size
--
Day's High
60.79
Day's Low
59.36
Volume
(Heavy Day)
Volume:
746,451

10-day average volume:
617,860
746,451

Company Profile

Globus Medical, Inc. is a medical device company. The Company is focused on developing products for patients with musculoskeletal disorders. It is focused on products to treat patients with spine disorders. The Company's products fall under categories, which include Innovative Fusion and Disruptive Technologies. The Innovative Fusion category products include fusion products to treat spinal disorders for the entire spine, and they can be used in various surgical approaches. The Disruptive Technologies category represents a shift in the treatment of spinal disorders by allowing for surgical procedures and the treatment of spinal disorders. QUARTEX is its Occipito-Cervico-Thoracic (OCT) stabilization system. QUARTEX features a threading locking cap to enable low-torque. The Company's portfolio of approved and pipeline Disruptive Technology products includes products that allow for minimally invasive surgical (MIS) techniques.

Valuation Ratios

Price/Earnings (TTM)
64.94x
Price/Sales (TTM)
7.71x
Price/Book (MRQ)
4.17x
Price/Cash Flow (TTM)
38.18x
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend No Regular Dividend is paid
 

Short Interest

November 2020
Current Month
2.0M
Previous Month
2.2M
Percent of Float
2.04%
Days to Cover
3.5263 Days

Share Information

GMED is in a share class of common stock
Float
75.2M
Shares Outstanding
98.7M
Institutions Holding Shares
457
67.17%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in millions.

Cash flow

Values displayed are in thousands.

Company Officers

  • David C. PaulChmn.
  • David M. DemskiPres.
  • Keith W. PfeilCFO
  • Daniel T. ScavillaExec.VP
  • Kelly Grace HullerSr.VP

Address

Insider Trading

During the most recent quarter, 2K shares were bought, and 416K shares were sold in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2020. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.